Mankind Pharma Limited (NSE:MANKIND)
India
· Delayed Price · Currency is INR 2,530.20
+68.40 (2.78%)
May 30, 2025, 10:30 AM IST
Mankind Pharma Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2024 | FY 2023 | FY 2023 | 2019 - 2022 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Mar '23 Mar 31, 2023 | 2019 - 2022 |
| Revenue | 122,074 | 122,074 | 103,348 | 102,604 | 87,494 | Upgrade
|
| Revenue Growth (YoY) | - | 18.12% | 0.72% | 17.27% | 12.44% | Upgrade
|
| Cost of Revenue | 34,890 | 34,890 | 33,207 | 31,985 | 30,031 | Upgrade
|
| Gross Profit | 87,184 | 87,184 | 70,141 | 70,620 | 57,463 | Upgrade
|
| Selling, General & Admin | 26,924 | 26,924 | 29,018 | 22,606 | 23,126 | Upgrade
|
| Other Operating Expenses | 30,081 | 30,081 | 15,622 | 22,877 | 15,195 | Upgrade
|
| Operating Expenses | 63,217 | 63,217 | 48,622 | 49,267 | 41,580 | Upgrade
|
| Operating Income | 23,967 | 23,967 | 21,518 | 21,353 | 15,883 | Upgrade
|
| Interest Expense | -4,294 | -4,294 | -286 | -327.5 | -402.74 | Upgrade
|
| Interest & Investment Income | - | - | 400.53 | - | 127.67 | Upgrade
|
| Earnings From Equity Investments | 122.4 | 122.4 | 152.14 | 152.1 | 124.24 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 86.36 | - | 104.06 | Upgrade
|
| Other Non Operating Income (Expenses) | 5,368 | 5,368 | 878.52 | 2,802 | 536.42 | Upgrade
|
| EBT Excluding Unusual Items | 25,163 | 25,163 | 22,750 | 23,979 | 16,372 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -38.52 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 1,295 | - | 374.31 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 4.8 | - | 16.65 | Upgrade
|
| Asset Writedown | - | - | -91.63 | - | -97.08 | Upgrade
|
| Other Unusual Items | - | - | 24.79 | - | 41.53 | Upgrade
|
| Pretax Income | 25,163 | 25,163 | 23,994 | 23,979 | 16,712 | Upgrade
|
| Income Tax Expense | 5,097 | 5,097 | 4,576 | 4,572 | 3,616 | Upgrade
|
| Earnings From Continuing Operations | 20,066 | 20,066 | 19,418 | 19,408 | 13,097 | Upgrade
|
| Earnings From Discontinued Operations | 45.3 | 45.3 | - | 9.8 | - | Upgrade
|
| Net Income to Company | 20,111 | 20,111 | 19,418 | 19,418 | 13,097 | Upgrade
|
| Minority Interest in Earnings | -201.6 | -201.6 | -288.75 | -288.7 | -278.17 | Upgrade
|
| Net Income | 19,910 | 19,910 | 19,129 | 19,129 | 12,819 | Upgrade
|
| Net Income to Common | 19,910 | 19,910 | 19,129 | 19,129 | 12,819 | Upgrade
|
| Net Income Growth | - | 4.08% | 0% | 49.23% | -10.58% | Upgrade
|
| Shares Outstanding (Basic) | 404 | 404 | 401 | 401 | 401 | Upgrade
|
| Shares Outstanding (Diluted) | 405 | 405 | 401 | 401 | 401 | Upgrade
|
| Shares Change (YoY) | - | 0.87% | -0.01% | 0.15% | 0.00% | Upgrade
|
| EPS (Basic) | 49.28 | 49.28 | 47.75 | 47.75 | 32.00 | Upgrade
|
| EPS (Diluted) | 49.20 | 49.20 | 47.68 | 47.68 | 32.00 | Upgrade
|
| EPS Growth | - | 3.19% | 0% | 49.00% | -10.57% | Upgrade
|
| Free Cash Flow | 19,526 | 19,526 | 18,371 | 18,371 | 10,243 | Upgrade
|
| Free Cash Flow Per Share | 48.25 | 48.25 | 45.79 | 45.79 | 25.57 | Upgrade
|
| Gross Margin | 71.42% | 71.42% | 67.87% | 68.83% | 65.68% | Upgrade
|
| Operating Margin | 19.63% | 19.63% | 20.82% | 20.81% | 18.15% | Upgrade
|
| Profit Margin | 16.31% | 16.31% | 18.51% | 18.64% | 14.65% | Upgrade
|
| Free Cash Flow Margin | 16.00% | 16.00% | 17.78% | 17.90% | 11.71% | Upgrade
|
| EBITDA | 30,179 | 30,179 | 25,366 | 25,335 | 19,051 | Upgrade
|
| EBITDA Margin | 24.72% | 24.72% | 24.54% | 24.69% | 21.77% | Upgrade
|
| D&A For EBITDA | 6,212 | 6,212 | 3,848 | 3,983 | 3,168 | Upgrade
|
| EBIT | 23,967 | 23,967 | 21,518 | 21,353 | 15,883 | Upgrade
|
| EBIT Margin | 19.63% | 19.63% | 20.82% | 20.81% | 18.15% | Upgrade
|
| Effective Tax Rate | 20.26% | 20.26% | 19.07% | 19.06% | 21.63% | Upgrade
|
| Revenue as Reported | 127,442 | 127,442 | 106,156 | 105,407 | 88,780 | Upgrade
|
| Advertising Expenses | - | - | 6,039 | - | 3,737 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.